Yesterday, Fuji Pharma and Alvotech announced their agreement to extend the companies’ exclusive partnership for the commercialization of four biosimilar medicines in Japan. We previously posted on that partnership when it was first announced in 2018, and later in 2019 when the companies reported that the partnership extended to Alvotech’s…